The Intraocular Pressure Rise Secondary to Subtenon's Injection of Triamcinolone After Intravitreal Injection.
10.3341/jkos.2008.49.1.91
- Author:
Wung Jae KIM
1
;
Young Hoon PARK
Author Information
1. Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Seoul, Korea. parkyh@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Intraocular pressure;
Subtenon injection;
Triamcinolone acetonide
- MeSH:
Eye;
Glaucoma;
Humans;
Intraocular Pressure;
Intravitreal Injections;
Prospective Studies;
Triamcinolone;
Triamcinolone Acetonide
- From:Journal of the Korean Ophthalmological Society
2008;49(1):91-97
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the safety of posterior subtenon's injection of triamcinolone acetonide (PSTA) after intravitreal triamcinolone acetonide injection (IVTA). METHODS: We reviewed the charts of 34 patients who had previously treated with IVTA. Patients were categorized as steroid responder or non-responder. Responders were defined as having a relative intraocular pressure increase of 5 mmHg and absolute intraocular pressure greater than 24 mmHg. Relative risk of intraocular pressure was prospectively evaluated after PSTA. RESULT: Eighteen eyes were categorized as steroid responders after IVTA injection and sixteen eyes were categorized as non-responders. For the actual amount of increase in the intraocular pressures, the steroid responder group (39%) was shown to be statistically higher than the non-responder group (6%) (P=0.044). However, the mean pressure values did not show a significant difference (P>0.05). Only one eye required the use of glaucoma medications and the intraocular pressure remained normal after treatment. CONCLUSIONS: PSTA is a relatively safe treatment method after IVTA injection regardless of steroid responsiveness.
